We work with innovators of biotech, healthcare, science, sustainability, and advanced technology
High-tech PR win: inside OSARO's robotic depalletization system launch campaign
Launching a new robotics solution is always a challenge. It's highly technical and can be difficult to translate for a general audience. That's why OSARO partnered with ZingPR to craft a compelling media strategy. Instead of focusing on specs, we highlighted the real-world benefits: warehouse safety and efficiency.
rBIO biosimilar insulin advances to clinical trials — strategy by ZingPR
rBIO's biosimilar insulin story landed in Wired, MedCity News, and more. See the PR tactics that drove success and get tips for your biotech launch.
2Pi Optics launches world's first metalens fisheye camera
With its patented technology that can extend metalens field of view (FOV) to almost 180 degrees without sacrificing imaging quality, 2Pi Optics outperforms conventional wide-FOV refractive optics in size, weight, performance, and cost.
CureLab's DNA vaccine prolongs the life of platinum-resistant ovarian cancer patients
CureLab Oncology’s DNA vaccine Elenagen, in combination with a proven chemotherapy, demonstrates promising clinical results against one of the deadliest forms of ovarian cancer.
Branding in action — how we're helping emerging science startups
It’s incredibly important to have a strong brand image and supporting story before you begin PR. Here are some of our recent branding and website success stories with some hugely promising science startups.
Gero is applying AI to crack the code of complex diseases and aging
Gero is a cutting-edge biotechnology company dedicated to the mission of curing age-related human diseases and understanding, slowing, and even halting the aging process itself.
AI and robotics combine to forge a new care pathway for lung cancer
By adopting the Optellum Virtual Nodule Clinic, the Interventional Pulmonology team at AtlantiCare's Lung Nodule Clinic, led by Amit Borah, M.D., interventional pulmonologist, can focus on identifying and systematically following up on patients with incidentally detected lung nodules.
Cyclica teams with Bill & Melinda Gates Foundation for non-hormonal contraceptives
Cyclica will apply its AI-enabled drug discovery platform to discover new therapeutic options with the goal of expanding the range of accessible non-hormonal contraceptive choices for women in developing countries.
GenScript and Avectas aim to reduce the cost of non-viral cell engineering
Two biotech leaders have embarked on a research project to streamline manufacturing of non-viral CRISPR gene editing components. Their goal is to improve the editing efficiency and cell viability of non-viral-based cell therapies.
CureLab Oncology's cancer therapy shows progress in clinical study
The clinical benefits currently delivered for terminally ill patients in CureLab’s clinical trial are already exceeding the benefits of new drugs recently approved by the FDA.
Luma Health debuts LumaPay — now patients can pay med bills via SMS
LumaPay™ enables patients to pay their bills right from text messages or their providers' websites. The announcement is part of a broader repositioning of Luma's focus on patient success.
GenScript enables new workflows for CRISPR HDR cell therapy development
GenScript’s new GMP-grade GenExact™ single-stranded DNA (ssDNA) and GenWand™ closed-end linear double-stranded DNA (dsDNA) services enable new workflows
Allelica and Invitae team to better identify women at risk for breast cancer
Allelica and Invitae want to integrate lifesaving genomic information into breast cancer risk assessments — for the benefit all women
Brickit, the killer app for LEGO enthusiasts, just got smarter!
Brickit uses clever AI to help kids build new creations with their LEGO bricks — and scores some super coverage across tech and consumer media.
Opalia’s animal-free milk is now one step closer to supermarket shelves
Opalia hits a key go-to-market milestone by eliminating fetal bovine serum from its cell-based milk manufacturing process
Polygenic risk score company Allelica adds US scientists to advisory board
Allelica, the leader in Polygenic Risk Scoring, expands scientific advisory board